Episodes

  • Managing Overactive Bladder: From Dual Diagnoses to Geriatric Challenges
    Mar 5 2025
    Wayne Kuang, MD; and Matt T. Rosenberg, MD, discuss how overactive bladder presents with distinct pathophysiological mechanisms between genders, requires different diagnostic approaches when distinguishing from benign prostatic hyperplasia in men, impacts quality of life in older adults, benefits from early primary care intervention, and necessitates improved patient advocacy and educational initiatives for optimal management outcomes.
    Show More Show Less
    41 mins
  • Current and Emerging Treatment Landscape of mHSPC
    Feb 24 2025
    Jack Andrews MD; Eugene Cone, MD; and Arash Rezazadeh, MD, discuss how metastatic hormone-sensitive prostate cancer presents clinically, explore current treatment standards including combination therapies, evaluate emerging data from the ARANOTE trial on darolutamide efficacy, consider quality of life factors in treatment selection, and examine how novel therapeutic approaches may reshape future care pathways.
    Show More Show Less
    36 mins
  • Managing Overactive Bladder: From Dual Diagnoses to Geriatric Challenges
    Jan 14 2025
    Panelists discuss how managing overactive bladder in older adults requires a holistic approach that integrates treatment of comorbidities, emerging therapeutic options, and quality-of-life considerations to optimize patient outcomes.
    Show More Show Less
    35 mins
  • Understanding Overactive Bladder (OAB): Pathophysiology, Diagnosis, and Management in Older Adults
    Nov 27 2024
    Experts discuss overactive bladder and the impacts on quality of life, distinguishing OAB from BPH, and how a delayed diagnosis can worsen symptoms.
    Show More Show Less
    49 mins
  • Generational Trends and Innovations in Retinal Disease Care
    23 mins
  • Optimizing Treatment Outcomes in Retinal Vein Occlusion
    20 mins
  • Addressing Suboptimal Anti-VEGF Response in Neovascular AMD and DME
    20 mins
  • Addressing Suboptimal Anti-VEGF Response in Neovascular AMD and DME
    21 mins